197 related articles for article (PubMed ID: 21040718)
1. Role of the effect of inhibition of neutral endopeptidase on vascular and neural complications in streptozotocin-induced diabetic rats.
Oltman CL; Davidson EP; Coppey LJ; Kleinschmidt TL; Dake B; Yorek MA
Eur J Pharmacol; 2011 Jan; 650(2-3):556-62. PubMed ID: 21040718
[TBL] [Abstract][Full Text] [Related]
2. Effect of inhibition of angiotensin converting enzyme and/or neutral endopeptidase on vascular and neural complications in high fat fed/low dose streptozotocin-diabetic rats.
Davidson EP; Coppey LJ; Holmes A; Yorek MA
Eur J Pharmacol; 2012 Feb; 677(1-3):180-7. PubMed ID: 22198047
[TBL] [Abstract][Full Text] [Related]
3. Effect of treatment of high fat fed/low dose streptozotocin-diabetic rats with Ilepatril on vascular and neural complications.
Davidson EP; Coppey LJ; Holmes A; Dake B; Yorek MA
Eur J Pharmacol; 2011 Oct; 668(3):497-506. PubMed ID: 21816138
[TBL] [Abstract][Full Text] [Related]
4. Treatment of streptozotocin-induced diabetic rats with AVE7688, a vasopeptidase inhibitor: effect on vascular and neural disease.
Davidson EP; Kleinschmidt TL; Oltman CL; Lund DD; Yorek MA
Diabetes; 2007 Feb; 56(2):355-62. PubMed ID: 17259379
[TBL] [Abstract][Full Text] [Related]
5. Effect of combination therapy consisting of enalapril, α-lipoic acid, and menhaden oil on diabetic neuropathy in a high fat/low dose streptozotocin treated rat.
Davidson EP; Holmes A; Coppey LJ; Yorek MA
Eur J Pharmacol; 2015 Oct; 765():258-67. PubMed ID: 26291662
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Zucker diabetic fatty rats with AVE7688 improves vascular and neural dysfunction.
Oltman CL; Davidson EP; Coppey LJ; Kleinschmidt TL; Yorek MA
Diabetes Obes Metab; 2009 Mar; 11(3):223-33. PubMed ID: 18564175
[TBL] [Abstract][Full Text] [Related]
7. Treatment of streptozotocin-induced diabetic rats with alogliptin: effect on vascular and neural complications.
Davidson EP; Coppey LJ; Dake B; Yorek MA
Exp Diabetes Res; 2011; 2011():810469. PubMed ID: 21822422
[TBL] [Abstract][Full Text] [Related]
8. ACE inhibitor or angiotensin II receptor antagonist attenuates diabetic neuropathy in streptozotocin-induced diabetic rats.
Coppey LJ; Davidson EP; Rinehart TW; Gellett JS; Oltman CL; Lund DD; Yorek MA
Diabetes; 2006 Feb; 55(2):341-8. PubMed ID: 16443766
[TBL] [Abstract][Full Text] [Related]
9. Vasopeptidase inhibitor ilepatril (AVE7688) prevents obesity- and diabetes-induced neuropathy in C57Bl/6J mice.
Coppey L; Davidson E; Lu B; Gerard C; Yorek M
Neuropharmacology; 2011; 60(2-3):259-66. PubMed ID: 20849865
[TBL] [Abstract][Full Text] [Related]
10. Effects of SA7060, a novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, on deoxycorticosterone acetate-salt-induced hypertension in rats.
Kuro T; Okahara A; Nose M; Ikuse T; Matsumura Y
Biol Pharm Bull; 2000 Jul; 23(7):820-5. PubMed ID: 10919359
[TBL] [Abstract][Full Text] [Related]
11. Impaired Corneal Sensation and Nerve Loss in a Type 2 Rat Model of Chronic Diabetes Is Reversible With Combination Therapy of Menhaden Oil, α-Lipoic Acid, and Enalapril.
Davidson EP; Coppey LJ; Shevalye H; Obrosov A; Kardon RH; Yorek MA
Cornea; 2017 Jun; 36(6):725-731. PubMed ID: 28476051
[TBL] [Abstract][Full Text] [Related]
12. Dual inhibition of angiotensin converting enzyme and neutral endopeptidase produces effective blood pressure control in spontaneously hypertensive rats.
Kostova E; Jovanoska E; Zafirov D; Jakovski K; Maleska V; Slaninka-Miceska M
Bratisl Lek Listy; 2005; 106(12):407-11. PubMed ID: 16642666
[TBL] [Abstract][Full Text] [Related]
13. Nerve conduction velocity and evoked potential latencies in streptozotocin-diabetic rats: effects of treatment with an angiotensin converting enzyme inhibitor.
Manschot SM; Gispen WH; Kappelle LJ; Biessels GJ
Diabetes Metab Res Rev; 2003; 19(6):469-77. PubMed ID: 14648806
[TBL] [Abstract][Full Text] [Related]
14. Dual inhibition of neutral endopeptidase and angiotensin-converting enzyme in rats with hypertension and diabetes mellitus.
Tikkanen T; Tikkanen I; Rockell MD; Allen TJ; Johnston CI; Cooper ME; Burrell LM
Hypertension; 1998 Oct; 32(4):778-85. PubMed ID: 9774379
[TBL] [Abstract][Full Text] [Related]
15. Neutral endopeptidase inhibitor versus angiotensin converting enzyme inhibitor in a rat model of the metabolic syndrome.
Eizenberg Y; Grossman E; Peleg E; Shabtai Z; Sharabi Y
J Am Soc Hypertens; 2014 Apr; 8(4):227-31. PubMed ID: 24560177
[TBL] [Abstract][Full Text] [Related]
16. Early vs. late intervention of high fat/low dose streptozotocin treated C57Bl/6J mice with enalapril, α-lipoic acid, menhaden oil or their combination: Effect on diabetic neuropathy related endpoints.
Yorek MS; Obrosov A; Shevalye H; Coppey LJ; Kardon RH; Yorek MA
Neuropharmacology; 2017 Apr; 116():122-131. PubMed ID: 28025096
[TBL] [Abstract][Full Text] [Related]
17. Early loss of innervation of cornea epithelium in streptozotocin-induced type 1 diabetic rats: improvement with ilepatril treatment.
Davidson EP; Coppey LJ; Yorek MA
Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8067-74. PubMed ID: 23169880
[TBL] [Abstract][Full Text] [Related]
18. Enalapril improves vascular and cardiac function in streptozotocin-diabetic rats.
Crespo MJ; Dunbar DC
Cell Mol Biol (Noisy-le-grand); 2003 Dec; 49(8):1311-8. PubMed ID: 14984003
[TBL] [Abstract][Full Text] [Related]
19. Vascular and neural dysfunction in Zucker diabetic fatty rats: a difficult condition to reverse.
Oltman CL; Davidson EP; Coppey LJ; Kleinschmidt TL; Lund DD; Adebara ET; Yorek MA
Diabetes Obes Metab; 2008 Jan; 10(1):64-74. PubMed ID: 17970755
[TBL] [Abstract][Full Text] [Related]
20. Combined inhibition of neutral endopeptidase with angiotensin converting enzyme or endothelin converting enzyme in experimental diabetes.
Tikkanen I; Tikkanen T; Cao Z; Allen TJ; Davis BJ; Lassila M; Casley D; Johnston CI; Burrell LM; Cooper ME
J Hypertens; 2002 Apr; 20(4):707-14. PubMed ID: 11910307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
